Healthtech Series C Investors & VC Firms
771 firms in this list, with a median first check of $1M. 164 of them lead rounds. Generated from verified public data and updated continuously.
Rho Ventures
New YorkPre-Seed–Late Stage$2M – $15M
10 people
2050
ParisSeed–Late Stage
29 people
Claret Capital Partners
LondonSeries A–Late Stage
29 people
Novartis Venture Fund
BaselPre-Seed–Late Stage$5M – $25M
25 people
CEI Ventures
BrunswickSeed–Late Stage$1M – $4M
18 people
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
28 people
LDC
LondonSeries B–Growth$12.7M – $127M
12 people
DG Daiwa Ventures
Pre-Seed–Growth
1 person
Parkwalk Advisors
LondonSeed–Growth
31 people
UKSE
SheffieldSeries A–Late Stage$31.8K – $1.3M
34 people
ACT Venture Capital
DublinSeed–Growth$1.1M – $16.2M
10 people
Spectrum Equity
BostonSeries A–Late Stage$25M – $250M
19 people
WI Harper Group
San FranciscoSeed–Series C$5M – $15M
25 people
Pan-Lin Capital
ShanghaiPre-Seed–Growth
5 people
SPRINGROCK VENTURES
SeattleSeed–Late Stage$2M – $5M
14 people
Lumira Ventures
TorontoPre-Seed–Late Stage$1M – $10M
17 people
Eagle Venture
Fort WorthPre-Seed–Series C
21 people
Geodesic Capital
Foster CitySeed–Late Stage
12 people
Unilever Ventures
LondonSeed–Late Stage$540K – $10.8M
15 people
Peregrine Ventures
Or YehudaSeed–Late Stage$500K – $3M
14 people
Samsung Catalyst Fund
San JoseSeed–Late Stage
14 people
Visionaries Club
BerlinPre-Seed–Late Stage$900K
16 people
Oregon Venture Fund
PortlandPre-Seed–Growth$500K – $5M
9 people
Panacea Venture
SingaporePre-Seed–Late Stage
20 people
Related lists
Healthtech Investors & VC Firms (3208)Series C Investors & VC Firms (2751)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Series C Investors & VC Firms in United States (946)Series C Investors & VC Firms in Global (896)
Data sourced from public filings and firms' own websites — see our methodology.












































































